Definium Therapeutics, Inc. - Common Shares (DFTX)

21.60
+0.18 (0.84%)
NASDAQ · Last Trade: Apr 10th, 3:01 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
This $6 Million Bet Adds a Brain Health Biotech to Portfolio Dominated by Clinical Stage Namesfool.com
This clinical-stage biopharma targets neurological and psychiatric disorders with a pipeline of novel therapeutics advancing through trials.
Via The Motley Fool · March 18, 2026
Definium (DFTX) Q4 2025 Earnings Call Transcriptfool.com
Definium (DFTX) Q4 2025 Earnings Call Transcript
Via The Motley Fool · February 27, 2026